Page last updated: 2024-09-03

3-n-methylspiperone and Dyskinesia, Medication-Induced

3-n-methylspiperone has been researched along with Dyskinesia, Medication-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coppens, HJ; Korf, J; Paans, AM; Slooff, CJ; Vaalburg, W; Wiegman, T	1

Other Studies

1 other study(ies) available for 3-n-methylspiperone and Dyskinesia, Medication-Induced

Article	Year
High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients. Biological psychiatry, 1991, Apr-01, Volume: 29, Issue:7 Topics: Adult; Antipsychotic Agents; Brain; Dyskinesia, Drug-Induced; Female; Humans; Male; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed	1991

Article

Year

High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.

Biological psychiatry, 1991, Apr-01, Volume: 29, Issue:7

Topics: Adult; Antipsychotic Agents; Brain; Dyskinesia, Drug-Induced; Female; Humans; Male; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed

1991